Mouse models of diabetic neuropathy.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  ILAR journal

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/ilar/ilt052PMID 24615439PMCID PMC3962259
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Signalling danger: endoplasmic reticulum stress and the unfolded protein response in pancreatic islet inflammation

  2013cited by this paper
• Endoplasmic reticulum stress contributes to prediabetic peripheral neuropathy.

  2013cited by this paper
• Apolipoprotein E knockout as the basis for mouse models of dyslipidemia-induced neuropathy.

  2013cited by this paper
• Endoplasmic Reticulum Stress Plays a Key Role in the Pathogenesis of Diabetic Peripheral Neuropathy

  2013cited by this paper
• Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodynia

  2013cited by this paper
• Bioenergetics in diabetic neuropathy: what we need to know

  2012cited by this paper
• Role of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy.

  2012cited by this paper
• Diabetic neuropathy: one disease or two?

  2012influential reference
• Overexpression of human HSP27 protects sensory neurons from diabetes.

  2012cited by this paper
• Glucagon-Like Peptide 1, Insulin, Sensory Neurons, and Diabetic Neuropathy

  2012cited by this paper
• Effect of Inhibition of Angiotensin-Converting Enzyme and/or Neutral Endopeptidase on Neuropathy in High-Fat-Fed C57Bl/6J Mice

  2012cited by this paper
• Special considerations of care and risk management for African American patients with type 2 diabetes mellitus.

  2012cited by this paper
• Inflammatory Mediators in Diabetic Neuropathy

  2012cited by this paper
• Protection from diabetes-induced peripheral sensory neuropathy--a role for elevated glyoxalase I?

  2012cited by this paper
• Diabetic neuropathy: clinical manifestations and current treatments.

  2012cited by this paper
• Coenzyme Q10 prevents peripheral neuropathy and attenuates neuron loss in the db−/db− mouse, a type 2 diabetes model

  2012cited by this paper
• Neuron–astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes

  2012cited by this paper
• Insulin resistance in the nervous system.

  2012cited by this paper
• Advancing animal models of human type 1 diabetes by engraftment of functional human tissues in immunodeficient mice.

  2012cited by this paper
• Comparative study of peripheral neuropathy and nerve regeneration in NOD and ICR diabetic mice

  2011cited by this paper
• Vasopeptidase inhibitor ilepatril (AVE7688) prevents obesity- and diabetes-induced neuropathy in C57Bl/6J mice.

  2011cited by this paper
• Progressive Erosion of β-Cell Function Precedes the Onset of Hyperglycemia in the NOD Mouse Model of Type 1 Diabetes

  2011influential reference
• Effect of varying dose and administration of streptozotocin on blood sugar in male CD1 mice.

  2011cited by this paper
• Effect of insulin and an erythropoietin-derived peptide (ARA290) on established neuritic dystrophy and neuronopathy in Akita (Ins2 Akita) diabetic mouse sympathetic ganglia.

  2011cited by this paper
• Phenotypic Changes in Diabetic Neuropathy Induced by a High-Fat Diet in Diabetic C57Bl/6 Mice

  2011influential reference
• Phosphodiesterase-5 is a therapeutic target for peripheral neuropathy in diabetic mice.

  2011influential reference
• Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice.

  2011cited by this paper
• Diabetic neuropathy: cellular mechanisms as therapeutic targets

  2011influential reference
• High-Fat Diet-Induced Neuropathy of Prediabetes and Obesity: Effect of PMI-5011, an Ethanolic Extract of Artemisia dracunculus L.

  2010cited by this paper
• Lack of both bradykinin B1 and B2 receptors enhances nephropathy, neuropathy, and bone mineral loss in Akita diabetic mice

  2010cited by this paper
• Is Lipotoxicity presents in the early stages of an experimental model of autoimmune diabetes? Further studies in the multiple low dose of streptozotocin model

  2010cited by this paper
• Prevalence of diabetes among men and women in China.

  2010cited by this paper
• Activation of protein kinase C isoforms and its impact on diabetic complications.

  2010cited by this paper
• Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments

  2010cited by this paper
• Prevalence of diabetes among men and women in China.

  2010cited by this paper
• Role of 12/15-lipoxygenase in nitrosative stress and peripheral prediabetic and diabetic neuropathies.

  2010cited by this paper
• Elevated Triglycerides Correlate With Progression of Diabetic Neuropathy

  2009influential reference
• Mouse Models for Type 1 Diabetes.

  2009cited by this paper
• Nerve Growth Factor Mediates Mechanical Allodynia in a Mouse Model of Type 2 Diabetes

  2009cited by this paper
• Hyperlipidemia: a new therapeutic target for diabetic neuropathy

  2009cited by this paper
• Dyslipidemia-Induced Neuropathy in Mice : the Role of oxLDL / LOX-1

  2009cited by this paper
• Dyslipidemia-Induced Neuropathy in Mice

  2009cited by this paper
• Early loss of peptidergic intraepidermal nerve fibers in an STZ‐induced mouse model of insensate diabetic neuropathy

  2008cited by this paper
• Metabolic effects of various antidiabetic and hypolipidaemic agents on a high‐fat diet and multiple low‐dose streptozocin (MLDS) mouse model of diabetes

  2008cited by this paper
• Abnormal Muscle Spindle Innervation and Large-Fiber Neuropathy in Diabetic Mice

  2008cited by this paper
• Criteria for creating and assessing mouse models of diabetic neuropathy.

  2008cited by this paper
• Dissociation of thermal hypoalgesia and epidermal denervation in streptozotocin-diabetic mice.

  2008cited by this paper
• Gender differences in the onset of diabetic neuropathy.

  2008cited by this paper
• Distal Degenerative Sensory Neuropathy in a Long-Term Type 2 Diabetes Rat Model

  2008cited by this paper
• Comparisons of diets used in animal models of high-fat feeding.

  2008cited by this paper
• Receptor for Advanced Glycation End Products (RAGEs) and Experimental Diabetic Neuropathy

  2008cited by this paper
• Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice.

  2008cited by this paper
• Selective changes in nocifensive behavior despite normal cutaneous axon innervation in leptin receptor–null mutant (db/db) mice

  2007influential reference
• Surrogate Markers of Small Fiber Damage in Human Diabetic Neuropathy

  2007cited by this paper
• Leptin‐deficient (ob/ob) mouse‐ a new animal model of peripheral neuropathy of Type 2 diabetes and obesity

  2007cited by this paper
• A Phytoestrogen-Rich Diet Increases Energy Expenditure and Decreases Adiposity in Mice

  2007cited by this paper
• Mouse models of diabetic neuropathy.

  2007influential reference
• SOD2 protects neurons from injury in cell culture and animal models of diabetic neuropathy.

  2007cited by this paper
• Protective Effects of Cyclooxygenase-2 Gene Inactivation Against Peripheral Nerve Dysfunction and Intraepidermal Nerve Fiber Loss in Experimental Diabetes

  2007cited by this paper
• Nitrosative stress and peripheral diabetic neuropathy in leptin-deficient (ob/ob) mice.

  2007cited by this paper
• High-Fat Diet–Induced Neuropathy of Pre-Diabetes and Obesity

  2007cited by this paper
• High-fat diet in low-dose-streptozotocin-treated heminephrectomized rats induces all features of human type 2 diabetic nephropathy: a new rat model of diabetic nephropathy.

  2006cited by this paper
• Defining high-fat-diet rat models: metabolic and molecular effects of different fat types.

  2006cited by this paper
• The Leptin-Deficient (ob/ob) Mouse

  2006cited by this paper
• Aldose Reductase Pathway Inhibition Improved Vascular and C-Fiber Functions, Allowing for Pressure-Induced Vasodilation Restoration During Severe Diabetic Neuropathy

  2006cited by this paper
• Experimental diabetic neuropathy with spontaneous recovery: is there irreparable damage?

  2005influential reference
• Low-dose poly(ADP-ribose) polymerase inhibitor-containing combination therapies reverse early peripheral diabetic neuropathy.

  2005cited by this paper
• Neuronal Nitric Oxide Synthase Mediates Statin-Induced Restoration of Vasa Nervorum and Reversal of Diabetic Neuropathy

  2005influential reference
• Genetic and genomic studies of the BTBR ob/ob mouse model of type 2 diabetes.

  2005cited by this paper
• Peripheral Nerve Dysfunction in Experimental Diabetes Is Mediated by Cyclooxygenase-2 and Oxidative Stress

  2005cited by this paper
• Hyperalgesia in non-obese diabetic (NOD) mice: a role for the inducible bradykinin B1 receptor.

  2005cited by this paper
• Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst

  2005cited by this paper
• Longitudinal evaluation of memory performance and peripheral neuropathy in the Ins2C96Y Akita mice.

  2005cited by this paper
• Reamputation, mortality, and health care costs among persons with dysvascular lower-limb amputations.

  2005cited by this paper
• Noninvasive monitoring of diabetes-induced cutaneous nerve fiber loss and hypoalgesia in thy1-YFP transgenic mice.

  2005cited by this paper
• Evaluation of orally active poly(ADP-ribose) polymerase inhibitor in streptozotocin-diabetic rat model of early peripheral neuropathy

  2004cited by this paper
• INGAP peptide improves nerve function and enhances regeneration in streptozotocin‐induced diabetic C57BL/6 mice

  2004cited by this paper
• Sciatic nerve morphology and morphometry in mature rats with streptozocin-induced diabetes

  2004cited by this paper
• Sonic Hedgehog Induces Arteriogenesis in Diabetic Vasa Nervorum and Restores Function in Diabetic Neuropathy

  2004cited by this paper
• Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients.

  2004cited by this paper
• Differential levels of diabetogenic stress in two new mouse models of obesity and type 2 diabetes.

  2004cited by this paper
• Differential regulation of Th1-type and Th2-type cytokine profiles in pancreatic islets of C57BL/6 and BALB/c mice by multiple low doses of streptozotocin.

  2002cited by this paper
• Downregulation of apoptosis in the target tissue prevents low-dose streptozotocin-induced autoimmune diabetes.

  2002cited by this paper
• Polyol pathway and diabetic peripheral neuropathy.

  2002cited by this paper
• Genotoxicity of streptozotocin.

  2002cited by this paper
• Effects of dietary fat types on body fatness, leptin, and ARC leptin receptor, NPY, and AgRP mRNA expression.

  2002cited by this paper
• Fat intake affects adiposity, comorbidity factors, and energy metabolism of sprague-dawley rats.

  2002cited by this paper
• Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials

  2001cited by this paper
• Reversal of experimental diabetic neuropathy by VEGF gene transfer.

  2001cited by this paper
• Painful sensory polyneuropathy associated with impaired glucose tolerance

  2001cited by this paper
• A novel small molecule that directly sensitizes the insulin receptor in vitro and in vivo.

  2001cited by this paper
• Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.

  2001cited by this paper
• Maternal environment and genotype interact to establish diabesity in mice.

  2000cited by this paper
• Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice.

  1998cited by this paper
• GLUT2 in Pancreatic Islets: Crucial Target Molecule in Diabetes Induced With Multiple Low Doses of Streptozotocin in Mice

  1998cited by this paper
• Peripheral neuropathy in transgenic diabetic mice: restoration of C-fiber function with human recombinant nerve growth factor.

  1998cited by this paper
• Nongenetic mouse models of non-insulin-dependent diabetes mellitus.

  1998cited by this paper
• A Novel Locus, Mody4, Distal to D7Mit189 on Chromosome 7 Determines Early-Onset NIDDM in Nonobese C57BL/6 (Akita) Mutant Mice

  1997cited by this paper
• The NOD Mouse: A Model for Insulin‐Dependent Diabetes Mellitus

  1997cited by this paper
• The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

  1997influential reference

• Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions.

  2026cites this paper
• Failure of nerve regeneration in mouse models of diabetes is caused by p35-mediated CDK5 hyperactivity.

  2025cites this paper
• TLR4 deletion reduces small fiber sensory abnormalities and nerve degeneration in diabetic male mice.

  2025cites this paper
• Nutrient metabolism and complications of type 2 diabetes mellitus: implications for rehabilitation and precision care

  2025cites this paper
• Lipid Transporter ABCA1 in Diabetic Polyneuropathy: Potential Mediation by Circulating Metabolites

  2025cites this paper
• Delta-9-tetrahydrocannabinol and Cannabidiol for Pain: Preclinical and Clinical Models.

  2025cites this paper
• Intravenous Streptozotocin Induces Variants in Painful Diabetic Peripheral Neuropathy in Female Mice

  2025cites this paper
• SMTP-44D prevents negative symptoms of diabetic neuropathy by inhibiting sciatic nerve apoptosis.

  2025cites this paper
• The Therapeutic Potential of Sodium-Glucose Cotransporter-2 Inhibitors in Diabetic Neuropathy

  2025cites this paper
• Cell-derived exosome therapy for diabetic peripheral neuropathy: a preclinical animal studies systematic review and meta-analysis

  2025cites this paper
• A comprehensive review of scientifically reported phytochemicals to manage allodynia in chronic diabetes complications.

  2025cites this paper
• Codelivery of NGFR100W and VEGFA mRNA Enhances Vascular and Neural Repair in Diabetic Peripheral Neuropathy.

  2025cites this paper
• Pretreatment with dimethyl fumarate prevents chronic pain and its comorbidities via Nrf2 pathway in a rat model of neuropathic pain.

  2025cites this paper
• Antioxidant and anti-inflammatory effects of SMTP-44D in a streptozotocin-induced diabetic neuropathy mouse model.

  2025cites this paper
• MoSeq based 3D behavioral profiling uncovers neuropathic behavior changes in diabetic mouse model

  2025cites this paper
• Aucubin mitigates the elevation of microglial aerobic glycolysis and inflammation in diabetic neuropathic pain via aldose reductase

  2025cites this paper
• Diabetic neuropathy: cutting-edge research and future directions

  2025cites this paper
• Intravenous streptozotocin induces variants in painful diabetic peripheral neuropathy in female mice

  2025cites this paper
• Rodent Models of Diabetic Neuropathy, Role of Calcium Homeostasis in Pain and KB-R7943 as a Potential Therapeutic

  2025cites this paper
• Novel three-dimensional analysis method for accurate evaluation of cutaneous small sensory nerve fibers in mice

  2025cites this paper
• Macrophages protect against sensory axon loss in peripheral neuropathy

  2025cites this paper
• Effect of 28 days treatment of baricitinib on mechanical allodynia, osteopenia, and loss of nerve fibers in an experimental model of type-1 diabetes mellitus

  2024cites this paper
• Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief

  2024cites this paper
• Continuous Glucose Monitoring in Comorbid Dementia and Diabetes: The Evidence So Far

  2024cites this paper
• Pre‐Clinical Assessment of Bupivacaine‐Loaded Poly(ester urea) Thin Films for Controlled Drug Release and Effective Pain Management After Surgery

  2024cites this paper
• Painful Diabetic Neuropathy: Sex-Specific Mechanisms and Differences from Animal Models to Clinical Outcomes

  2024cites this paper
• Leptin deficiency leads to nerve degeneration and impairs axon remyelination by inducing Schwann cell apoptosis and demyelination in type 2 diabetic peripheral neuropathy in rats.

  2024cites this paper
• Development of Diabetic Neuropathy in C57BL/6 Mice in the Setting of a High-Fat Diet

  2024cites this paper
• Epigenetic modifications associated to diabetic peripheral neuropathic pain (Review)

  2024cites this paper
• Antinociceptive Behavior, Glutamine/Glutamate, and Neopterin in Early-Stage Streptozotocin-Induced Diabetic Neuropathy in Liraglutide-Treated Mice under a Standard or Enriched Environment

  2024cites this paper
• Antioxidant Effect in Diabetic Peripheral Neuropathy in Rat Model: A Systematic Review

  2024cites this paper
• Neuroinflammation evoked mechanisms for neuropathic itch in the spared nerve injury mouse model of neuropathic pain.

  2024cites this paper
• Diverse calcium signaling profiles regulate migratory behavior in avascular wound healing and aberrant signal hierarchy occurs early in diabetes.

  2024cites this paper
• Impact of streptozotocin-induced diabetes on experimental masseter pain in rats

  2024cites this paper
• Navigating Preclinical Models and Medications for Peripheral Neuropathy: A Review

  2024cites this paper
• Branched‐Chain Amino Acids Deficiency Promotes Diabetic Neuropathic Pain Through Upregulating LAT1 and Inhibiting Kv1.2 Channel

  2024cites this paper
• Obesity-related neuropathy: the new epidemic

  2024cites this paper
• Interaction of serotonin/GLP-1 circuitry in a dual preclinical model for psychiatric disorders and metabolic dysfunction.

  2024cites this paper
• Age-dependent small fiber neuropathy: Mechanistic insights from animal models.

  2024cites this paper
• Skin keratinocyte-derived SIRT1 and BDNF modulate mechanical allodynia in mouse models of diabetic neuropathy.

  2024cites this paper
• Artificial light at night alters progression of cold neuropathy in a sex-dependent manner in a mouse model of type II diabetes mellitus

  2024cites this paper
• Polychlorinated biphenyls exposure and type 2 diabetes: Molecular mechanism that causes insulin resistance and islet damage

  2024cites this paper
• Sarm1 knockout prevents type 1 diabetic bone disease in females independent of neuropathy

  2024cites this paper
• Identification of Adipogenesis Subgroups and Immune Infiltration Characteristics in Diabetic Peripheral Neuropathy

  2023cites this paper
• The impact of heat therapy on neuromuscular function and muscle atrophy in diabetic rats

  2023cites this paper
• The Effect of Sevoflurane and Fullerenol C 60 on the Liver and Kidney in Lower Extremity Ischemia-Reperfusion Injury in Mice with Streptozocin-Induced Diabetes

  2023cites this paper
• Defective autophagy contributes to bupivacaine-induced aggravation of painful diabetic neuropathy in db/db mice.

  2023cites this paper
• Actualización práctica sobre la palmitoiletanolamida (PEAum) oral en el manejo del dolor crónico. Revisión narrativa

  2023cites this paper
• Non‐invasive in vivo measurements of metabolic alterations in the type 2 diabetic brain by 1H magnetic resonance spectroscopy

  2023cites this paper
• Animal Models of Type 2 Diabetes Complications: A Review

  2023influential citation
• SUMOylation Modulates Reactive Oxygen Species (ROS) Levels and Acts as a Protective Mechanism in the Type 2 Model of Diabetic Peripheral Neuropathy

  2023cites this paper
• Assessment of Inner Blood–Retinal Barrier: Animal Models and Methods

  2023cites this paper
• Comparison of western diet-induced obesity and streptozotocin mouse models: insights into energy balance, somatosensory dysfunction, and cardiac autonomic neuropathy

  2023cites this paper
• Establishment of a Neurodegenerative Charcot Mouse Model

  2023cites this paper
• Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes

  2023cites this paper
• Lipin2 ameliorates diabetic encephalopathy via suppressing JNK/ERK-mediated NLRP3 inflammasome overactivation.

  2023cites this paper
• Acid-sensing ion channel 3 mediates pain hypersensitivity associated with high-fat diet consumption in mice.

  2023cites this paper
• Aberrations in Cell Signaling Quantified in Diabetic Murine Globes after Injury

  2023cites this paper
• Promotion of degradative autophagy by 6‐bromoindirubin‐3′‐oxime attenuates neuropathy

  2023cites this paper
• Evaluation of the effects of sinapic acid and ellagic acid on sciatic nerve in experimental diabetic rats by immunohistochemical and stereological methods.

  2023cites this paper
• Review on in-vitro Techniques and in-vivo Animals Models for Screening Diabetes and Diabetic Complications.

  2023cites this paper
• Glycogen synthesis kinase-3β involves in the analgesic effect of liraglutide on diabetic neuropathic pain.

  2023cites this paper
• Skin keratinocyte-derived SIRT1 and BDNF modulate mechanical allodynia in mouse models of diabetic neuropathy

  2023cites this paper
• Novel Nanotechnological Approaches for Targeting Dorsal Root Ganglion (DRG) in Mitigating Diabetic Neuropathic Pain (DNP)

  2022cites this paper
• COMPARATIVE EFFECT OF A HIGH FAT WITH OR WITHOUT HIGH LEVELS OF SUCROSE DIETS ON PERIPHERAL NEUROPATHY IN C57BL/6J MICE.

  2022cites this paper
• The therapeutic effect of Salvia spinosa on diabetic neuropathy induced by STZ via attenuation of the oxidative pathway

  2022cites this paper
• Mechanisms and treatments of neuropathic itch in a mouse model of lymphoma

  2022cites this paper
• Interactions between NSAIDs, opioids and the gut microbiota - Future perspectives in the management of inflammation and pain.

  2022cites this paper
• Moderate intensity aerobic training reduces the signs of peripheral sensitization in a mouse model of type 2 diabetes mellitus

  2022cites this paper
• The Influence of Diabetic Peripheral Neuropathy on the Duration of Sciatic Nerve Block with 1.3% Liposomal Bupivacaine and 0.25% Bupivacaine Hydrochloride in a Mouse Model

  2022cites this paper
• Identification and quantification of nociceptive Schwann cells in mice with and without Streptozotocin-induced diabetes.

  2022cites this paper
• Selection of experimental models mimicking human pathophysiology for diabetic microvascular complications

  2022cites this paper
• Sphingolipid metabolism plays a key role in diabetic peripheral neuropathy

  2022cites this paper
• The ocular surface and diabetes, the other 21st Century epidemic.

  2022cites this paper
• Systems Biology to Address Unmet Medical Needs in Neurological Disorders.

  2022cites this paper
• New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors

  2022cites this paper
• Insulin enhances neurite extension and myelination of diabetic neuropathy neurons

  2022cites this paper
• Peripheral Neuropathy Phenotyping in Rat Models of Type 2 Diabetes Mellitus: Evaluating Uptake of the Neurodiab Guidelines and Identifying Future Directions

  2022cites this paper
• The Role of Long Non-coding RNA MALAT1 in Diabetic Polyneuropathy and the Impact of its Silencing in the Dorsal Root Ganglion by a DNA/RNA Heteroduplex Oligonucleotide.

  2022cites this paper
• Poly (ADP‐ribose) polymerase 1‐mediated defective mitophagy contributes to painful diabetic neuropathy in the db/db model

  2022cites this paper
• Obesity-Associated Neuropathy: Recent Preclinical Studies and Proposed Mechanisms

  2022influential citation
• A Role for Fatty Acids in Peripheral Neuropathy Associated with Type 2 Diabetes and Prediabetes

  2022cites this paper
• CNS-Sparing Histamine H3 Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms

  2022cites this paper
• The Endocannabinoid System as a Therapeutic Target in Diabetic Peripheral Neuropathic Pain: A Review

  2021cites this paper
• Juglanin protects against high fat diet-induced renal injury by suppressing inflammation and dyslipidemia via regulating NF-κB/HDAC3 signaling.

  2021cites this paper
• Neuropathic pain modeling: focus on synaptic and ion channel mechanisms.

  2021cites this paper
• Sex differences in insulin resistance, but not peripheral neuropathy, in a diet-induced prediabetes mouse model

  2021cites this paper
• High Dietary Fat Consumption Impairs Axonal Mitochondrial Function In Vivo

  2021cites this paper
• Gene expression profiles of diabetic kidney disease and neuropathy in eNOS knockout mice: Predictors of pathology and RAS blockade effects

  2021cites this paper
• Treatment for diabetic peripheral neuropathy: What have we learned from animal models?

  2021cites this paper
• Cutaneous Innervation in Impaired Diabetic Wound Healing.

  2021cites this paper
• Investigating auranofin for the treatment of infected diabetic pressure ulcers in mice and dermal toxicity in pigs

  2021cites this paper
• Ammonium Glycyrrhizinate Prevents Apoptosis and Mitochondrial Dysfunction Induced by High Glucose in SH-SY5Y Cell Line and Counteracts Neuropathic Pain in Streptozotocin-Induced Diabetic Mice

  2021cites this paper
• Toll-Like Receptor 2 Antagonist Ameliorates Type 2 Diabetes Mellitus Associated Neuropathic Pain by Repolarizing Pro-inflammatory Macrophages

  2021cites this paper
• Diet, body weight and pain susceptibility – A systematic review of preclinical studies

  2021cites this paper
• RETRACTED: A Synthetic Peptide Designed to Neutralize Lipopolysaccharides Attenuates Metaflammation and Diet-Induced Metabolic Derangements in Mice

  2021cites this paper
• Targeting Neuroimmune Interactions in Diabetic Neuropathy with Nanomedicine

  2021cites this paper
• Experimental animal models for diabetes and its related complications—a review

  2021cites this paper
• Advances in diet-induced rodent models of metabolically acquired peripheral neuropathy

  2021cites this paper
• The PPARγ agonist pioglitazone produces a female-predominant inhibition of hyperalgesia associated with surgical incision, peripheral nerve injury, and painful diabetic neuropathy.

  2021cites this paper